0001225208-12-016000.txt : 20120706 0001225208-12-016000.hdr.sgml : 20120706 20120706121058 ACCESSION NUMBER: 0001225208-12-016000 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20120701 FILED AS OF DATE: 20120706 DATE AS OF CHANGE: 20120706 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Flynn Karen CENTRAL INDEX KEY: 0001553599 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-08036 FILM NUMBER: 12949952 MAIL ADDRESS: STREET 1: 101 GORDON DRIVE CITY: LIONVILLE STATE: PA ZIP: 19341 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: WEST PHARMACEUTICAL SERVICES INC CENTRAL INDEX KEY: 0000105770 STANDARD INDUSTRIAL CLASSIFICATION: FABRICATED RUBBER PRODUCTS, NEC [3060] IRS NUMBER: 231210010 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 101 GORDON DR STREET 2: P O BOX 645 CITY: LIONVILLE STATE: PA ZIP: 19341-0645 BUSINESS PHONE: 6105942900 MAIL ADDRESS: STREET 1: 101 GORDON DRIVE STREET 2: PO BOX 645 CITY: LIONVILLE STATE: PA ZIP: 19341-0645 FORMER COMPANY: FORMER CONFORMED NAME: WEST CO INC DATE OF NAME CHANGE: 19990405 3 1 doc3.xml X0206 3 2012-07-01 0 0000105770 WEST PHARMACEUTICAL SERVICES INC WST 0001553599 Flynn Karen 101 GORDON DRIVE LIONVILLE PA 19341 1 President, America's Region Common Stock 3474.7818 D Common Stock 155.8650 I By Savings Plan Stock Option (Right to Buy) 32.0900 2010-02-24 2019-02-24 Common Stock 2500.0000 D Stock Option (Right to Buy) 40.8500 2012-02-22 2021-02-22 Common Stock 4281.0000 D Stock Option (Right to Buy) 42.4400 2013-02-21 2022-02-21 Common Stock 4729.0000 D Stock Option (Right to Buy) 42.6800 2011-03-22 2020-03-22 Common Stock 4729.0000 D Stock Option (Right to Buy) 45.7800 2009-06-11 2018-06-11 Common Stock 2750.0000 D limitedpowerflynn.txt Joanne K. Boyle as Agent for Karen Flynn 2012-07-06 EX-24 2 limitedpowerflynn.txt LIMITED POWER OF ATTORNEY FOR WEST PHARMACEUTICAL SERVICES, INC. SECTION 16(a) FILINGS Know all by these presents that the undersigned hereby constitutes and appoints each of John R. Gailey III, Joanne K. Boyle and Rachael M. Bushey, signing singly, the undersigned's true and lawful attorney-in-fact to: (1) Execute for and on behalf of the undersigned, in the undersigned's capacity as an officer, director and/or shareholder of West Pharmaceutical Services, Inc. (the "Company"), Forms 3, 4, and 5 and amendments thereto in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder; (2) Do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5 or amendment thereto and timely file such form with the United States Securities and Exchange Commission (the "SEC") and any stock exchange or similar authority; and (3) Take any other action of any type whatsoever, which, in the opinion of such attorney-in-fact, may be necessary or desirable in connection with the foregoing authority, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve. The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of and transaction in securities of the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. This Power of Attorney may be filed with the SEC as a confirming statement of the authority granted herein. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 2nd day of July 2011. _____________________________ /s/ Karen Flynn Page 3 of 3 - 2 - G:\stockmatters\limitedpowerflynn.doc